127 related articles for article (PubMed ID: 34602409)
1. Lamotrigine loaded nano-liposomes enhance brain selectivity in vivo.
Song N; Zhang C; Wang S; Guan Y
Pak J Pharm Sci; 2021 May; 34(3):875-882. PubMed ID: 34602409
[TBL] [Abstract][Full Text] [Related]
2. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
[TBL] [Abstract][Full Text] [Related]
3. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy.
Wang ML; Tao YY; Sun XY; Guo Y; Wang ZY; Cao YF; Zhao L
Pharmacol Res; 2021 Jul; 169():105610. PubMed ID: 33857625
[TBL] [Abstract][Full Text] [Related]
4. Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery.
Liu J; He Y; Zhang J; Li J; Yu X; Cao Z; Meng F; Zhao Y; Wu X; Shen T; Hong Z
Biomaterials; 2016 Jan; 74():64-76. PubMed ID: 26447556
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine pharmacokinetics following oral and stable-labeled intravenous administration in young and elderly adult epilepsy patients: Effect of age.
Polepally AR; Brundage RC; Remmel RP; Leppik IE; Pennell PB; White JR; Ramsay RE; Kistner BM; Birnbaum AK
Epilepsia; 2018 Sep; 59(9):1718-1726. PubMed ID: 30101556
[TBL] [Abstract][Full Text] [Related]
6. Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrier.
Liu JS; Wang JH; Zhou J; Tang XH; Xu L; Shen T; Wu XY; Hong Z
Int J Nanomedicine; 2014; 9():3923-35. PubMed ID: 25152622
[TBL] [Abstract][Full Text] [Related]
7. Short-term effects of Garcinia cambogia extract on the pharmacokinetics of lamotrigine given as a single-dose in Wistar rats.
Ventura S; Rodrigues M; Falcão A; Alves G
Food Chem Toxicol; 2019 Jun; 128():61-67. PubMed ID: 30940594
[TBL] [Abstract][Full Text] [Related]
8. Safety evidence on the administration of
Ventura S; Rodrigues M; Falcão A; Alves G
Drug Chem Toxicol; 2020 Nov; 43(6):560-566. PubMed ID: 30332899
[No Abstract] [Full Text] [Related]
9. Evaluation of the effects of Citrus aurantium (bitter orange) extract on lamotrigine pharmacokinetics: Insights from in vivo studies in rats.
Ventura S; Rodrigues M; Falcão A; Alves G
Food Chem Toxicol; 2018 Nov; 121():166-172. PubMed ID: 30172847
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: Formulation design, characterization and nasal toxicity study.
Praveen A; Aqil M; Imam SS; Ahad A; Moolakkadath T; Ahmad FJ
Colloids Surf B Biointerfaces; 2019 Feb; 174():553-562. PubMed ID: 30502666
[TBL] [Abstract][Full Text] [Related]
11. Cubosome-based thermosensitive
Mohsen AM; Salama AAA; Asfour MH
Pharm Dev Technol; 2023 Jul; 28(6):520-534. PubMed ID: 37213179
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy.
Ding Y; Tan X; Zhang S; Guo Y
Brain Behav; 2019 Jul; 9(7):e01315. PubMed ID: 31104352
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study.
Matsuo F; Gay P; Madsen J; Tolman KG; Rollins DE; Risner ME; Lai AA
Epilepsia; 1996 Sep; 37(9):857-62. PubMed ID: 8814098
[TBL] [Abstract][Full Text] [Related]
14. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
[TBL] [Abstract][Full Text] [Related]
15. [The clinical significance of the lamotrigine pharmacokinetic variability].
Noskova TY; Abaimov DA; Sariev AK; Fedin PA; Krasnikov AV; Shvedkov VV; Sejfulla RD
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):23-29. PubMed ID: 29460901
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study.
Shah P; Dubey P; Vyas B; Kaul A; Mishra AK; Chopra D; Patel P
Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):511-522. PubMed ID: 34151674
[TBL] [Abstract][Full Text] [Related]
18. Once-daily lamotrigine extended release for epilepsy management.
Rheims S; Ryvlin P
Expert Rev Neurother; 2009 Feb; 9(2):167-73. PubMed ID: 19210192
[TBL] [Abstract][Full Text] [Related]
19. Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy.
Ortega-Vázquez A; Fricke-Galindo I; Dorado P; Jung-Cook H; Martínez-Juárez IE; Monroy-Jaramillo N; Rojas-Tomé IS; Peñas-Lledó E; Llerena A; López-López M
Pharmacogenomics J; 2020 Dec; 20(6):845-856. PubMed ID: 32483200
[TBL] [Abstract][Full Text] [Related]
20. Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment.
Abdelmonem R; El-Enin HAA; Abdelkader G; Abdel-Hakeem M
Drug Deliv; 2023 Dec; 30(1):2163321. PubMed ID: 36579655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
